Abstract
Despite record-breaking numbers of liver transplants (LTs) performed in the United States in each of the last 7 years, many patients remain on the wait list as the demand for LT continues to exceed the supply of available donors. The emergence of highly effective and well-tolerated direct-acting antiviral therapy has transformed the clinical course and management of hepatitis C virus (HCV) in both the pretransplant and posttransplant setting. Historically, donor livers infected with HCV were either transplanted into patients already infected with HCV or discarded.
Original language | English (US) |
---|---|
Pages (from-to) | 195-207 |
Number of pages | 13 |
Journal | Clinics in liver disease |
Volume | 25 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2021 |
Keywords
- HCV-positive donor
- HCV-viremic donor
- Hepatitis C virus
- Liver transplantation
ASJC Scopus subject areas
- Hepatology